Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
3.6
3.6
Journals
Diagnostics
Special Issues
New Progress in Diagnosis and Management of Cardiovascular Diseases
share announcement

New Progress in Diagnosis and Management of Cardiovascular Diseases

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".

Deadline for manuscript submissions: 31 July 2024 | Viewed by 1398

Special Issue Editor

Dr. Hyemoon Chung

E-Mail Website
Guest Editor
Division of Cardiology, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University, Seoul 02447, Republic of Korea
Interests: cardiovascular diseases; cardiomyopathy; atrial fibrillation

Special Issue Information

Dear Colleagues,

Cardiovascular disease is one of the leading causes of death. Due to aging populations, changes in lifestyle and increases in other risk factors, the incidence and mortality rates of cardiovascular disease continue to rise. Timely diagnosis can help detect potential cardiovascular disorders, which is crucial for developing precise treatment plans and evaluating patient outcomes. 

Recent advances in the diagnosis of cardiovascular disease include constantly improving imaging techniques and molecular biology applications. The development of cardiovascular imaging techniques (such as echocardiography, MRI and CT) provides an important means for an early, rapid and accurate diagnosis of diseases. Progress in molecular biology has also provided new ideas and methods for the diagnosis of cardiovascular disease.

The Special Issue aims to share new advances in the diagnosis and management of cardiovascular diseases. Research articles and comprehensive reviews that focus on any of these aspects are welcome. Potential topics include, but are not limited to:

(1) Cardiovascular imaging;
(2) Pathogenesis of cardiovascular diseases;
(3) Biomarkers for the diagnosis and prognosis of cardiovascular diseases;
(4) Artificial intelligence in cardiovascular medicine. 

We look forward to receiving your contributions.

Dr. Hyemoon Chung
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cardiovascular disease
  • cardiovascular imaging
  • biomarker
  • cardiomyopathy
  • atrial fibrillation

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Review

16 pages, 808 KiB  
Review
Emerging Trends in Left Ventricular Thrombus: A Comprehensive Review of Non-Ischemic and Ischemic Cardiopathies, Including Eosinophilic Myocarditis, Chagas Cardiomyopathy, Amyloidosis, and Innovative Anticoagulant Approaches
by Benjamin Colle, Fabian Demeure, Julien Higny, Martin Benoit, Jean-Philippe Henry, Isabelle Michaux, Benoit Robaye, Olivier Xhaët, Laurence Gabriel, Antoine Guedes, Dominique Blommaert, Nathalie Dulieu, Yannick Berners, Fabian Wery, Steven Droogmans, Bernard Cosyns and Maria-Luiza Luchian
Diagnostics 2024, 14(9), 948; https://doi.org/10.3390/diagnostics14090948 - 30 Apr 2024
Viewed by 1204
Abstract
This comprehensive review explores the intricate aspects of left ventricular thrombus (LVT), a potential complication in both ischemic and non-ischemic cardiomyopathies. It provides a thorough understanding of left ventricular thrombus, revealing its uncommon incidence in the general population (7 cases per 10,000 patients), [...] Read more.
This comprehensive review explores the intricate aspects of left ventricular thrombus (LVT), a potential complication in both ischemic and non-ischemic cardiomyopathies. It provides a thorough understanding of left ventricular thrombus, revealing its uncommon incidence in the general population (7 cases per 10,000 patients), predominantly linked to ischemic heart diseases (ICMs) at an 80% prevalence rate. Diagnostic tools, notably transthoracic echocardiography (TTE) and cardiac magnetic resonance imaging (CMR), demonstrate varying sensitivity but remain indispensable in specific clinical contexts related to LVT as non-invasive diagnostic modalities. A detailed comparison between ICM patients and those with non-ischemic cardiomyopathy (NICM) who have left ventricular thrombus reveals subtle distinctions with significant clinical implications. This analysis underscores the importance of these imaging techniques in distinguishing between the two conditions. Additionally, we explored the occurrence of LVT in specific non-ischemic cardiomyopathies, including Takotsubo syndrome, hypertrophic cardiomyopathy, eosinophilic myocarditis, Chagas disease, cardiac amyloidosis, and several other conditions. The article further delves into anticoagulation strategies, thoroughly examining their impact on LVT regression and patient outcomes. Pharmacological interventions, with a focus on direct oral anticoagulants, emerge as promising alternatives; however, there is insufficient information on their efficiency and safety, especially in NICM population. In conclusion, this review highlights the complex nature of LVT, incorporating a range of etiopathogenic factors, diagnostic complexities, and evolving therapeutic approaches. It emphasizes the pressing need for ongoing research in this field. Full article
(This article belongs to the Special Issue New Progress in Diagnosis and Management of Cardiovascular Diseases)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop